Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of the weekly biotech podcast, “The Readout Loud.” You can reach Allison on Signal at AllisonDeAngelis ...

Performances in N.Y.C. Advertisement Supported by Daphne Rubin-Vega stars as a laid-off office worker who spins into a murderous rage in this update of Elmer L. Rice’s 1923 classic. By Laura ...

Emily Long is a freelance writer based in Salt Lake City. After graduating from Duke University, she spent several years reporting on the federal workforce for Government Executive, a publication of ...

This is read by an automated voice. Please report any issues or inconsistencies here. It’s a good time for Elmer Rice’s “The Adding Machine,” which can only mean that it’s once again a bad time for ...

Forbes contributors publish independent expert analyses and insights. John Sviokla covers GenAI/AI's impact on commerce and society. This voice experience is generated by AI. Learn more. This voice ...

Recursive language models (RLMs) are an inference technique developed by researchers at MIT CSAIL that treat long prompts as an external environment to the model. Instead of forcing the entire prompt ...

Upcoming film “Number One” has unveiled new stills of Gong Seung Yeon in character! “Number One” follows Ha Min (Choi Woo Shik), who one day begins seeing a number that drops by one every time he eats ...

Recursion Pharmaceuticals developed a promising artificial intelligence (AI) platform for drug discovery and development. The company's clinical-stage pipeline is just the tip of the iceberg of its ...

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage assets. RXRX's AI-driven drug discovery model is ambitious, but pipeline value ...

In AI research, progress is often equated with size. But a small team at Samsung’s AI lab in Montreal has taken another approach that is proving to show great promise. Their new Tiny Recursive Model ...